Crosslinking Salivary Diagnosis with Non-Invasive Insights to Oral Pathology: Novel Systematic Insights to Personalized Medicine in Disease Management
DOI:
https://doi.org/10.51253/pafmj.v75i3.13199Keywords:
Biomarkers, Disease Progression, Histopathology, Molecular Diagnostics, Non-Invasive Imaging, Oral Cancer Personalized Medicine, Oral Pathology.Abstract
Objective: To explore the integration of salivary biomarkers, histopathological validation, and advanced imaging for precision diagnosis and management of oral diseases.
Methodology: A systematic review was conducted in accordance with the PRISMA 2020 guidelines. Relevant studies from PubMed, Scopus, and Google Scholar were analyzed, with a focus on biomarker discovery, validation, and non-invasive diagnostic modalities in oral pathology. Data extraction emphasized study design, salivary biomarker specificity, imaging correlations, and clinical utility. The risk of bias was assessed using the QUADAS-2 tool, and the GRADE criteria were used to determine the evidence quality.
Results: Among the 15 studies included, 6 investigated salivary biomarkers for oral cancer detection, five evaluated non-invasive imaging modalities, and four explored molecular diagnostics in disease progression. Salivary biomarkers (e.g., IL-6, miRNA-21) demonstrated high specificity (AUC >0.85) in distinguishing between malignant and benign lesions. Non-invasive imaging enhanced diagnostic accuracy by 37% (p<0.001). Combined approaches improved early detection and treatment personalization.
Conclusion: Salivary diagnostics offer a powerful, non-invasive tool for personalized disease management in oral pathology. Integrating molecular biomarkers and imaging could revolutionize early detection, reducing the need for invasive procedures and enhancing patient outcomes. Further research is needed to validate biomarker-driven precision medicine strategies.
Downloads
References
Gorania R, Hunter K, Hall G, Brierley DJ. Independent reporting in oral and maxillofacial pathology. J Clin Pathol 2023; 76(12): 822–826.
https://doi.org/10.1136/jcp-2022-208495
Iqbal K, Fatima K, Minhas M, Siddiqui AU, Khizer B, Anique M, et al. Diagnostic modalities in oral pathology: Integrating advanced diagnostic techniques to differentiate malignant and benign lesions. Pak J Health Sci 2024; 5(1): 331–338.
https://doi.org/10.54393/pjhs.v5i12.2535
Kaczor-Urbanowicz KE, Martin Carreras-Presas C, Aro K, Tu M, Garcia-Godoy F, Wong DT. Saliva diagnostics: Current views and directions. Exp Biol Med 2017; 242(5): 459–472.
https://doi.org/10.1177/1535370216681550
Chiamulera MMA, Zancan CB, Remor AP, Cordeiro MF, Gleber-Netto FO, Baptistella AR. Salivary cytokines as biomarkers of oral cancer: a systematic review and meta-analysis. BMC Cancer 2021; 21(1): 205.
https://doi.org/10.1186/s12885-021-07932-3
Ojha A, Panda B, Mishra P, Das D, Kumar V, Bhuyan L. New Horizons and Prospects in Oral Cancer Detection. J Pharm Bioallied Sci 2024; 16(Suppl 2): S1072-S1076.
https://doi.org/10.4103/jpbs.jpbs_1179_23
Jeng MJ, Sharma M, Sharma L, Huang SF, Chang LB, Wu SL, et al. Novel Quantitative Analysis Using Optical Imaging (VELscope) and Spectroscopy (Raman) Techniques for Oral Cancer Detection. Cancers 2020; 12(11): 3364.
https://doi.org/10.3390/cancers12113364
Romano A, Di Stasio D, Petruzzi M, Fiori F, Lajolo C, Santarelli A, et al. Noninvasive Imaging Methods to Improve the Diagnosis of Oral Carcinoma and Its Precursors: State of the Art and Proposal of a Three-Step Diagnostic Process. Cancers 2021; 13(12): 2864.
https://doi.org/10.3390/cancers13122864
Li Y, Ou Y, Fan K, Liu G. Salivary diagnostics: opportunities and challenges. Theranostics 2024; 14(18): 6969-6990.
https://doi.org/10.7150/thno.100600
Bostanci N, Mitsakakis K, Afacan B, Bao K, Johannsen B, Baumgartner D et al. Validation and verification of predictive salivary biomarkers for oral health. Sci Rep 2021; 11(1): 6406.
https://doi.org/10.1038/s41598-021-85120-w
Haj-Hosseini N, Lindblad J, Hasséus B, Kumar VV, Subramaniam N, Hirsch JM. Early Detection of Oral Potentially Malignant Disorders: A Review on Prospective Screening Methods with Regard to Global Challenges. J Maxillofac Oral Surg 2024; 23(1): 23-32.
https://doi.org/10.1007/s12663-022-01710-9
Chang PY, Kuo YB, Wu TL, Liao CT, Sun YC, Yen TC, et al. Association and prognostic value of serum inflammation markers in patients with leukoplakia and oral cavity cancer. Clin Chem Lab Med 2013; 51(6): 1291-1300.
https://doi.org/10.1515/cclm-2012-0504
Vageli DP, Doukas PG, Shah R, Boyi T, Liu C, Judson BL. A Novel Saliva and Serum miRNA Panel as a Potential Useful Index for Oral Cancer and the Association of miR-21 with Smoking History: a Pilot Study. Cancer Prev Res 2023; 16(12): 653-659.
https://doi.org/10.1158/1940-6207.CAPR-23-0219
Sharma M, Li YC, Manjunatha SN, Tsai CL, Lin RM, Huang SF, et al. Identification of Healthy Tissue from Malignant Tissue in Surgical Margin Using Raman Spectroscopy in Oral Cancer Surgeries. Biomedicines 2023; 11(7): 1984.
https://doi.org/10.3390/biomedicines11071984
Carreras-Torras C, Gay-Escoda C. Techniques for early diagnosis of oral squamous cell carcinoma: Systematic review. Med Oral Patol Oral Cir Bucal 2015; 20(3): e305-315.
https://doi.org/10.4317/medoral.20347
Kalbassi S, Radfar L, Azimi M, Shadanpoor S, Ghorbani Ranjbary A. A Comparison of the Characteristics of Cytokine Storm between Lichen Planus and Oral Squamous Cell Carcinoma. Asian Pac J Cancer Prev 2022; 23(11): 3843-3849.
https://doi.org/10.31557/APJCP.2022.23.11.3843
Dikova V, Jantus-Lewintre E, Bagan J. Potential Non-Invasive Biomarkers for Early Diagnosis of Oral Squamous Cell Carcinoma. J Clin Med 2021; 10(8): 1658.
https://doi.org/10.3390/jcm10081658
Panzarella V, Buttacavoli F, Rodolico V, Maniscalco L, Firenze A, De Caro V, et al. Application of Targeted Optical Coherence Tomography in Oral Cancer: A Cross-Sectional Preliminary Study. Diagnostics 2024; 14(19): 2247.
https://doi.org/10.3390/diagnostics14192247
Di Giorgi N, Cecchettini A, Michelucci E, Signore G, Ceccherini E, Ferro F et al. Salivary Proteomics Markers for Preclinical Sjögren's Syndrome: A Pilot Study. Biomolecules 2022; 12(6): 738.
https://doi.org/10.3390/biom12060738
Chang YT, Chu LJ, Liu YC, Chen CJ, Wu SF, Chen CH, et al. Verification of Saliva Matrix Metalloproteinase-1 as a Strong Diagnostic Marker of Oral Cavity Cancer. Cancers 2020; 12(8): 2273. https://doi.org/10.3390/cancers12082273
Yeladandi M, Sundaram UTN, Muthukumaran D. A Cross-Sectional Study on Oral Potentially Malignant Disorders: Diagnostic Challenges in Early Detection of Dysplasia and the Role of Velscope. Cureus 2024; 16(9): e69542.
https://doi.org/10.7759/cureus.69542
Bastías D, Maturana A, Marín C, Martínez R, Niklander SE. Salivary Biomarkers for Oral Cancer Detection: An Exploratory Systematic Review. Int J Mol Sci 2024; 25(5): 2634.
https://doi.org/10.3390/ijms25052634
Chiabotto G, Gai C, Deregibus MC, Camussi G. Salivary Extracellular Vesicle-Associated exRNA as Cancer Biomarker. Cancers 2019; 11(7): 891.
https://doi.org/10.3390/cancers11070891
Jurmeister P, Leitheiser M, Arnold A, Capilla EP, Mochmann LH, Zhdanovic Y, et al. DNA Methylation Profiling of Salivary Gland Tumors Supports and Expands Conventional Classification. Mod Pathol 2024; 37(12): 100625.
https://doi.org/10.1016/j.modpat.2024.100625
Park NJ, Zhou H, Elashoff D, Henson BS, Kastratovic DA, Abemayor E, et al. Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection. Clin Cancer Res 2009; 15(17): 5473-5477.
https://doi.org/10.1158/1078-0432.CCR-09-0736
Ngamchuea K, Chaisiwamongkhol K, Batchelor-McAuley C, Compton RG. Correction: Chemical analysis in saliva and the search for salivary biomarkers - a tutorial review. Analyst 2018; 143(3): 777-783. https://doi.org/10.1039/c7an90101a
Pittman TW, Decsi DB, Punyadeera C, Henry CS. Saliva-based microfluidic point-of-care diagnostic. Theranostics 2023; 13(3): 1091-1108. https://doi.org/10.7150/thno.78872
Shakeeb N, Varkey P, Ajit A. Human Saliva as a Diagnostic Specimen for Early Detection of Inflammatory Biomarkers by Real-Time RT-PCR. Inflammation 2021; 44(5): 1713-1723.
https://doi.org/10.1007/s10753-021-01484-1
Logan D, Wallace SM, Woodside JV, McKenna G. The potential of salivary biomarkers of nutritional status and dietary intake: A Systematic Review. J Dent 2021; 115: 103840.
https://doi.org/10.1016/j.jdent.2021.103840
d'Amone L, Matzeu G, Omenetto FG. Stabilization of Salivary Biomarkers. ACS Biomater Sci Eng 2021; 7(12): 5451-5473.
https://doi.org/10.1021/acsbiomaterials.1c01138
Shakeeb N, Varkey P, Ajit A. Human Saliva as a Diagnostic Specimen for Early Detection of Inflammatory Biomarkers by Real-Time RT-PCR. Inflammation 2021; 44(5): 1713-1723.
https://doi.org/10.1007/s10753-021-01484-1
Ahmad P, Hussain A, Siqueira WL. Mass spectrometry-based proteomic approaches for salivary protein biomarkers discovery and dental caries diagnosis: A critical review. Mass Spectrom Rev 2024; 43(4): 826-856. https://doi.org/10.1002/mas.21822
Chaurasia A, Namachivayam A, Koca-Ünsal RB, Lee JH. Deep-learning performance in identifying and classifying dental implant systems from dental imaging: a systematic review and meta-analysis. J Periodontal Implant Sci 2024; 54(1): 3-12.
https://doi.org/10.5051/jpis.2300160008
Nonaka T, Wong DTW. Saliva diagnostics: Salivaomics, saliva exosomics, and saliva liquid biopsy. J Am Dent Assoc 2023; 154(8): 696-704. https://doi.org/10.1016/j.adaj.2023.05.006
Adeola HA, Bello IO, Aruleba RT, Francisco NM, Adekiya TA, Adefuye AO, et al. The Practicality of the Use of Liquid Biopsy in Early Diagnosis and Treatment Monitoring of Oral Cancer in Resource-Limited Settings. Cancers 2022; 14(5): 1139.
Downloads
Published
License
Copyright (c) 2025 Rehana Kausar, Attia Batool, Ashfaq Ahmad Shah Bukhari, Abdul Rehman Khalil Shaikh, Abdul Aleem, Madeeha Minhas, Muhammad Hussain

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.